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ABSTRACT 
Cadherin-17 (CDH17) is a novel adhesion molecule that expresses abundantly in fetal liver 
but is silenced in healthy adult. Recently, we have identified CDH17 is a cancer biomarker 
which is over-expressed in ~80% of hepatocellular carcinomas that associated with poor 
clinical outcomes. The present study aims to identify the transcription factor(s) and 
elucidate the regulatory mechanisms that drive CDH17 gene over-expression in human 
HCC.  A 1-kb upstream sequence of CDH17 gene was cloned and the promoter activity 
was studied by luciferase reporter assay.  By bioinformatics analysis, deletion and 
mutation assays, and chromatin immunoprecipitation studies, we identified hepatic nuclear 
factor 1α (HNF1α) and caudal-related homeobox 2 (CDX2) binding sites at the proximal 
(-81/+55 region relative to the transcriptional start site) promoter region which modulate 
the CDH17 promoter activities in two HCC cell lines (Hep3B and MHCC97L). 
Interestingly, the expression of CDH17 was high in mouse fetal livers (E13.5> E16.5> 
newborn> 3 weeks> adult) as well as in human HCC cell lines with higher metastatic 
potential (MHCC97L> Hep3B> MIHA), which is in concomitant with the expression 
levels of HNF1α and CDX2 mRNA and proteins. Furthermore, knockdown of HNF1α and 
CDX2 by small interfere RNA (siRNA) significantly decrease CDH17 transcript level in 
the transfected HCC cells. In sum, we identified -81/+55 region of CDH17 as minimal 
promoter region that is regulated by HNF1α and CDX2.  The expression levels of these 
transcriptional factors as well as CDH17, may serve as biomarkers for HCC, and may be 
potential targets for cancer treatment. 
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INTRODUCTION 
 Hepatocellular carcinoma (HCC) ranks the fifth most common malignancy in the 
world [Llovet et al., 2003]. Hepatic resection and liver transplantation are the mainstays of 
surgical management for HCC, but the 5-year survival rate is still poor [Liu and Fan, 2006; 
Poon and Fan, 2004]. Early diagnosis and treatment of HCC remain challenging due to lack 
of highly specific and sensitive markers. The currently used serological tumor marker for 
HCC, α-fetoprotein (AFP), lacks specificity and sensitivity [Johnson, 2001]. 
 Liver-Intestine cadherin (LI-cadherin), or CDH17 (cadherin-17) is a member of 
non-classical cadherin family [Jung et al., 2004] and located on chromosome 8q21.1 
[Dantzig et al., 1994]. Beside the cell adhesion function, CDH17 was initially identified as 
a proton-dependent peptide transporter-1 in human colon adenocarcinoma Caco-2 cells 
[Dantzig et al., 1994]. CDH17 is over-expressed in gastric metaplasia and gastric 
carcinoma 42 associated with lymph node metastasis [Grotzinger et al., 2001; 
Kaposi-Novak et al., 2006; Ko et al., 2004; Ko et al., 2005], as well as in pancreatic 
carcinoma [Takamura et al., 2003]. Recently, our group has reported CDH17 is 
over-expressed in HCC and is associated with poor survival rate and a higher tumor 
recurrence [Wang et al., 2005; Wong et al., 2003]. In human, over-expression of CDH17 is 
frequently detected in ~80% HCC cases, but the corresponding regulatory mechanisms 
remain largely unclear. 
 Recently, CDX2 was found to play important role(s) in up-regulation of CDH17 
expression in colorectal cancer cell lines and gastric adenocarcinoma [Hinoi et al., 2002; 
Ko et al., 2005], which was in turn was regulated by bone morphogenetic protein 2 (BMP2) 
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and BMP4 in gastric cancer cells [Barros et al., 2008]. 
 HNF1 is one of the key transcriptional factors that regulate serum α-fetoprotein 
levels in hepatocellular carcinoma [Nakabayashi et al., 2004].  It is predominantly 
expressed in liver and kidney, and binds to the promoters of a variety of genes that are 
expressed exclusively in the liver including fibrinogen-α and -β, albumin, α-1-antitrypsin, 
liver-type pyruvate kinase, transthyretin, aldolase B, and hepatitis B virus large surface 
protein [Courtois et al., 1987; Xu et al., 2001]. Over-expression of HNF1α was found in 
well-differentiated HCC than in the surrounding non-HCC tissues [Wang et al., 1998]. 
 In this study, we aimed to dissect the regulation of CDH17 expression in HCC 
and in mouse live during development, and functionally characterized two transcription 
factors (HNF1α and CDX2) on CDH17 expression.  The specific regulation of these 
transcriptional factors was confirmed by RNAi approach in the transfected HCC cells. 
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MATERIALS AND METHODS 
 
Plasmids, bacteria and reagents 
The Dual-Luciferase® reporter assay system and the pGL3-Basic, pGL3-Control and 
pRL-TK reporter vectors were obtained from Promega (Madison, WI). E. coli DH5α 
competent cells were prepared by chemical method. Restriction endonucleases, T4 DNA 
ligase and T4 polynucleotide kinase were purchased from New England Biolabs (Ipswich, 
MA). Bradford reagent was purchased from Bio-Rad (Hercules, CA) and all other reagents 
were purchased from Sigma (St. Louis, MO). 
 
Mouse liver and clinical HCC tissues 
The use of animal in this study protocol was approved by the Using Live Animals for 
Teaching and Research (CULATR), The University of Hong Kong. Informed written 
consent was obtained from patients and the usage of clinical tissues for this study was 
vetted and approved by the Institutional Review Board of the University of Hong 
Kong/Hospital Authority Hong Kong West Cluster.  Messenger RNA and protein lysates 
were extracted from BALB/c mouse livers at different stages: embryonic day 13.5 (E13.5), 
E16.5, new-borne (NB), postnatal (3 weeks), and adult (3 months). 
 
Cloning of 5’-promoter region of the CDH17 gene 
The promoter region of the human CDH17 gene (NM_004063.3) was predicted and 
analyzed using the NCBI Map Viewer (http://www.ncbi.nlm.nih.gov/mapview). The 
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promoter fragment starting at -909bp and ending at +55bp was amplified by PCR using 
specific forward primer 5’-TAGAGAGTGGGCTGGGCTC-3’ and reverse primer 
5’-TGGTCGAGACTCTTGCTACG-3’ and Pfu Turbo high-fidelity DNA polymerase 
(Stratagene, La Jolla, CA). In brief, PCR was carried out at 94 °C for 5 min and then 30 
cycles at 94 °C for 40 s, 60 °C for 1 min, and 72 °C for 3 min and a final extension step at 
72 °C for 10 min in a final reaction volume of 25 µl. The genomic DNA of HCC cell line 
MHCC97L was used as template and the CDH17 gene promoter was cloned by directional 
restriction cloning method [Lee et al., 2009; Wong et al., 2003]. 
 
Constructs of CDH17 mutant promoters 
Another four deletion constructs (-686/+55, -332/+55, -81/+55 and -40/+55) were 
generated by PCR cloning with the following forward primers 
(5’-GAAGCCTTGACTTGAGAAAT-3’, 5’-TGATCAAGTCTCCTGTGCT-3’, 
5’-AGTGGCTCTCGAAGAGCAAT-3’, and 5’-TTTGACTGAAGCTGAAGGG-3’), 
respectively. These five CDH17 promoter constructs were cloned to the pGL3-Basic vector 
by XhoI/KpnI restriction digestions. For site-directed mutagenesis, mutated promoter 
constructs were generated using the QuickChange mutagenesis kit (Stratagene). All 
deletion and point-mutation constructs were sequenced with an ABI 3700 Genetic Analyzer 
(Applied Biosystems Inc., Foster City, CA). 
 
Cell Cultures and transfection 
The human HCC cell lines MHCC97L and Hep3B and a normal immortalized human 
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hepatocyte cell line MIHA were cultured in Dulbecco’s minimal essential medium (Life 
Technologies, Carlsbad, CA), supplemented with 10% fetal bovine serum, 50 U/ml 
penicillin, 50 U/ml streptomycin and 2 mM L-glutamine at 37 °C and 5% CO2.  For 
transfection, cells were grown to about 90% confluence in a 24-well tissue culture plate and 
then added with 500 µl of serum-free medium containing 2 µl lipofectamine™ 2000 
reagent (Invitrogen, Carlsbad, CA) mixed with 1 µg of purified plasmid cDNA and 0.1 µg 
of pRL-TK vector (the internal control reporter) per well. Followed by incubation at 37°C 
for 48 h, the promoter activity of the CDH17 gene was assessed by measuring luciferase 
activity using the Dual-Luciferase® reporter assay (Promega). The intensity of 
chemiluminscence was measured in a luminometer (Thermo, Waltham, MA). All 
experiments were performed in duplicate and repeated at least three times with positive 
(pGL3-Control) and negative (pGL3-Basic) controls. 
 
Western blotting 
Antibodies against CDX2 and β-actin were purchased from Millipore (Billerica, MA) and 
Sigma (St Loius, MO), respectively.  Antibodies against CDH17, HNF1α and HNF1β 
were from Santa Cruz Biotechnology (Santa Cruz, CA). Protein extracts from the liver of 
BALB/c mice at different developmental stages and from different cell lines MHCC97L, 
Hep3B and MIHA was prepared. In brief, cells were washed twice with ice-cold phosphate 
buffered saline (PBS) and then incubated in the lysis buffer (50 mM Tris-HCl pH 8, 150 
mM NaCl, 1% NP-40) on ice for 30 min. After centrifugation at 4 °C for 15 min at 14,000g, 
the supernatant (30 µg per lane) was collected and resolved on a 10% SDS-PAGE. Proteins 
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on the gel were then transferred onto a polyvinylidene fluoride membrane (0.4-µm pore 
size; Millipore). Non-specific protein binding onto the membrane was blocked with 
Tris-buffered saline containing 0.1% Tween 20 (TBST) and 5% non-fat milk at 4°C 
overnight [Lee et al., 2006]. After washing three times with TBST, the membrane was 
incubated with the primary antibodies (1:500 in TBST containing 5% non-fat milk) at room 
temperature for 1 h. After washing with TBST, bound antibodies were detected by 
horseradish peroxidase (HRP)-conjugated secondary antibodies (1:20,000 dilution) and 
ECL reagent (Amersham Biosciences). The immunoreactive signals were developed on 
Kodak® Biomax™ MS film. 
 
Quantitative PCR 
Total RNA was isolated from cell cultures or frozen tissues using Trizol reagent 
(Invitrogen). Two micrograms of total RNA were used to synthesize first-strand cDNA 
using random hexamer primers and reverse transcriptase (Promega). A 5 µl aliquot of 1:10 
diluted cDNA was mixed with 10 µl SYBR® GreenERTM qPCR superMix (Invitrogen) 
and 0.5 µM of the designated primers (Table 1). The thermal cycling conditions were 50 °C 
for 2 minutes, 95 °C for 10 minutes, followed by 40 cycles at 95 °C for 15 seconds and 
60 °C for 1 minute. All reactions were done at least twice and the products were analyzed 
using the ABI Prism 7700 detection system (Applied Biosystems Inc.). Ribosomal 18S 
RNA was included in all reactions for internal house-keeping control and normalization. 
 
Electromobility shift assay (EMSA) 
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Nuclear protein extracts from MHCC97L and Hep3B cells were prepared as described 
previously [Luk et al., 2004], and the amount of protein extract was quantified using the 
Bradford protein assay kit (Bio-Rad). Double-strand oligonucleotide probes were 
synthesized with annealing buffer (200 mM Tris-HCl;pH 9.0, 40mM MgCl2, 1 M NaCl, 20 
mM EDTA) and labeled with [ -32P] ATP (PerkinElmer, Waltham, MA) using the 
Ready-To-Go T4 Polynucleotide Kinase kit (Amersham BioSciences) with T4 
polynucleotide kinase. Unincorporated nucleotides were removed by spin column in a 
Tris-EDTA buffer, pH 8.0. An aliquot (10 µg) of nuclear extract was incubated with or 
without 1µl unlabeled oligonucleotide probes or the previously described antibodies in 1x 
binding buffer (4% glycerol, 1 µg poly(dI–dC).(dI–dC), 10 mM Tris–HCl (pH 7.5), 50 mM 
NaCl, 1 mM MgCl2, 0.5 mM EDTA and 0.5 mM DTT) in a 10 µl reaction volume for 20 
min at room temperature. Radiolabeled probe was added to each reaction tube and the tubes 
were incubated for a further 20 min at room temperature. The reaction products were then 
resolved on a 5% non-denaturing polyacrylamide gel. The gels were dried under vacuum 
and autoradiographed on Kodak® Biomax™ MS films overnight at -70°C. 
 
Chromatin Immunoprecipitation (ChIP) assay 
Standard ChIP assays were performed with Millipore ChIP Assay kit according to the 
manufacturer’s instructions. Briefly, approximately 1 x 106 cells were cross-linked using 
1% formaldehyde at 37°C for 10 min, washed twice with PBS, and then resuspended in 
200 µl SDS lysis buffer containing 1x protease inhibitor cocktail (Roche Applied Science, 
Indianapolis, IN) and 10 mM of DTT. After incubation on ice for 10 min, the cells were 
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sonicated (Sonic Dismembrator Model 100, Fisher Scientific, Waltham, MA) four times at 
20% maximum power for 10 s and the lysate was centrifuged at 4°C for 15 min at 14,000g. 
The resultant supernatant was diluted 1:10 with a dilution buffer containing a protease 
inhibitor. Twenty microliter of the diluted supernatant was collected as input control before 
immunoprecipitation. After precleared with 75 µL of salmon sperm DNA/protein A agarose 
(50% slurry) for 1 hour at 4°C with agitation, the immune complexes were incubated at 
4°C overnight with either 2 µg of primary antibodies or IgG control, and then recovered 
with 60 µl of salmon sperm DNA/protein A agarose 50% slurry at 4°C for 1 hour. 
Precipitates were washed once sequentially with washing solutions provided by the 
manufacturer (Millipore), and finally with two washes of TE buffer. Chromatin complexes 
were incubated at room temperature for 15 min with 250 µl of elution buffer containing 1% 
SDS and 100mM sodium bicarbonate. The eluate was reverse cross-linked by heating at 
65°C for 4 hours with 200 mM NaCl and 200 mg/ml proteinase K. The DNA was 
recovered by phenol/chloroform extraction and ethanol precipitation and then amplified by 
PCR with forward primer 5’-GTGCTAAGTGTTGGGGGTACAA-3’ and reverse primer 
5’-TTGACTGAAGCTGAAGGGAGAG-3’. PCR was carried out at 94 °C for 5 min and 
then 30 cycles at 94 °C for 40 s, 60 °C for 1 min, and 72 °C for 1 min and a final extension 
step at 72 °C for 10 min in a final volume of 25 µl. 
 
HNF1α and CDX2 siRNA knockdown 
Small interference RNA (siRNA) was used to knockdown the expression of HNF1α and 
CDX2 in HCC cells (MHCC97L and Hep3B). RNA oligonucleotides were designed 
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according to the published sequences [Hinoi et al., 2005]. HCC cells were transfected with 
the designated siRNA duplex or scramble control using Lipofectamine™ 2000 (Invitrogen) 
as described above. After 48-hour incubation, both mRNA and protein extracts were 
purified for qPCR and Western blot analyses, respectively. 
 
Statistical analysis 
All results are represented as mean ± S.D.  Statistical comparisons were performed by 
One-way ANOVA or paired Student’s t-test using the SPSS statistical software package 
version 13.0 for Window (SPSS Inc., Chicago, IL) and p<0.05 was considered to be 
statistically significant. 
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RESULTS 
 
Cloning and characterization of CDH17 gene promoter 
CDH17 promoter region was amplified by PCR and cloned into pGL3-Basic reporter 
vector. The position and sequence of the primers used to generate the parental fragment and 
the four deletion constructs were shown in Figure 1A. Two bioinformatics programs, 
ALGGEN-PROMO (http://alggen.lsi.upc.es) and MatInspector (http://www.genomatix.de) 
were used to identify potential transcription factors at the -909/+55 promoter region and the 
results were compared to the transcription factor database TRANSFAC (version 8.3). A 
conserved CAAT box, but not the TATA-box, was found in the CDH17 gene promoter 
region. Interestingly, two putative transcription factors, HNF1 and CDX2 were identified. 
At this stage, the binding of HNF1α from HNF1β cannot be differentiated as they shared 
similar binding sequences. There are three putative binding sites for each HNF1 and CDX2 
transcription factors in the CDH17 promoter, respectively. Figure 1B shows the luciferase 
reporter activities of different promoter deletion constructs when compared to the parental 
(-909/+55) control in two different HCC cell lines: MHCC97L (CDH17high) and Hep3B 
(CDH17low). The data indicated that CDX2 and HNF1α are two critical factors for the 
transcription of CDH17 because the luciferase activities decreased significantly from the 
pGL-81/+55Luc to pGL3-40/+55Luc. Both cell lines exhibited similar activity patterns 
although the signals were generally stronger in the MHCC97L cell line. 
To confirm the functional roles of these transcriptional factors (TF), point 
mutations were introduced at the TF core binding sites in the CDH17 promoter sequence. 
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Reporter activities were markedly reduced for HNF1 mutant (-47/-45, p<0.01), followed by 
the CDX2 mutant (-91/-89, p<0.05) (Fig. 2). Mutations on other HNF1 and CDX2 binding 
sites did not drastically reduce promoter activities. Double mutations on the HNF1 (-47/-45) 
and CDX2 (-91/-89) binding sites reduced the CDH17 reporter activity to near basal level. 
 
Binding of CDX2 and HNF1α to CDH17 promoter in vitro and in vivo 
The binding of HNF1 and CDX2 to the CDH17 gene promoter in MHCC97L and Hep3B 
cells were studied by EMSA and ChIP assays. As shown in Fig. 3A, both the HNF1α and 
CDX2 wild-type (WT), but not the mutant probes were able to complexes with the HCC 
lysates. Further, addition of 10 and 50-fold excess of “cold” WT probes, but not the mutant 
probes, could displace or compete with the binding. Moreover, CDX2, HNF1α, but not 
HNF1β antibodies were able to retard the migration of the DNA-protein complex, 
suggesting the binding of the nuclear extract is specific. Meanwhile, the ChIP assay was 
performed to study TF-DNA interactions in vivo. After immunoprecipitation by designated 
antibodies, the recovered DNA was amplified by PCR using CDH17 promoter-specific 
primers spanning from -318 to -18 regions. Positive signals were detected by the HNF1α 
and CDX2, but not the HNF1β and isotype control (Fig. 3B). 
 
Differential expression of CDH17, HNF1 and CDX in HCC and fetal mouse liver 
Luciferase reporter assays revealed differential promoter activities in Hep3B and 
MHCC97L cell lines (Fig. 1B and Fig. 2). To study if the endogenous CDH17 transcript 
level correlates with the HNF1α and CDX2 expression levels, we determined the 
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expression of these transcripts in HCC cells and mouse livers at different developmental 
stages.  MHCC97L which has a high metastatic potential also expressed a high level of 
CDH17 transcript as well as the CDX2 and HNF1α transcripts; whereas the primary HCC 
(Hep3B) and MIHA (immortalized normal human hepatocyte) expressed at a lower or 
undetectable levels of the gene (Fig. 4A). 
 Since CDH17 plays important roles during embryonic liver development, the 
expression of CDH17 and TFs levels in mouse liver at different development stages (E13.5, 
E16.5, newborn, 3 weeks and adult) were measured. Bioinformatics analysis of these 
transcriptional factor binding sites on CDH17 promoter between mouse, rat and human are 
highly conserved using ClustalW2 program (http://www.ebi.ac.uk/ 
Tools/clustalw2/index.html), suggesting a conserved regulatory mechanism of CDH17 
expression among different animal species (data not shown). It was found that CDH17 
expressed abundantly in the early embryonic liver, but the expression of the gene becomes 
undetectable in late fetal stages and adult livers (Fig. 4A). Similar to the human HCC 
findings, the differential expression of CDH17 transcript in mouse liver largely correlated 
with the patterns of HNF1α and CDX2 levels. The result was supported by Western blot 
analysis of the CDH17, HNF1α and CDX2 protein levels (Fig. 4B). Interestingly, the 
decreases of CDH17 and HNF1a were more drastic in both human HCC cells and mouse 
livers, than the CDX2. 
 
Knockdown of HNF1α and CDX2 suppress CDH17 expression 
To demonstrate HNF1α and CDX2 regulate CDH17 expression, we used siRNA approach 
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to knockdown HNF1α and CDX2 expression and study the expression of CDH17 in 
MHCC97L cells (Fig. 5). RNAi-mediated targeting HNF1α or CDX2 lowered the mRNA 
level of the respective transcriptional factor (HNF1α or CDX2) by approximate 50%, when 
compared with the vehicle or scramble control. These down-regulations were accompanied 
with significant reduction of CDH17 transcript level in MHCC97L cells (p< 0.05). An 
additive effect of combined HNF1α or CDX2 RNAi treatment on CDH17 suppression was 
also observed, indicating a coordinate regulation of HNF1α and CDX2 in the cells. 
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DISCUSSION 
Liver-intestine cadherin or cadherin-17 (CDH17) is expressed in the rat liver and intestinal 
epithelial cells [Angres et al., 2001], as well as in the embryonic mouse liver [Takamura et 
al., 2004], but no CDH17 expression was detected in normal liver tissue of mature humans 
and mice [Takamura et al., 2003]. CDH17 is involved in the maintenance of tissue integrity, 
tissue growth and differentiation [Berndorff et al., 1994]. Aberrant expression of CDH17 
mRNA and protein was found in upper gastrointestinal malignancies including liver cancer 
[Wang et al., 2006; Wang et al., 2005; Wong et al., 2003]. In this study, we demonstrated 
that the expression of CDH17 is regulated by HNF1α and CDX2 transcriptional factors in 
HCC and mouse liver. 
 The human CDH17 gene promoter has a conserved CAAT box at the -65/-62 
position, but lacks the TATA box, an initiator element in the predominant control region of 
typical eukaryotic genes [Suzuki et al., 2001]. In both primary and metastatic human HCC 
cell lines, the minimal CDH17 promoter (-81/-40) region contains one CDX2 and two 
HNF1 sites that mediated strong promoter activity in vitro. Further deletion of this minimal 
promoter region diminished the reporter activity to near basal levels. We also found that the 
transactivation activitiy of the pGL3-81/+55Luc construct was similar to longer constructs 
(up to -909 position).  Although the deletion construct pGL3-332/+55Luc shown a 
decrease in promoter activity, the reason behind is still unknown.  It is possible that an 
enhancer sequence is located at -686 and -332 region, and a repressor sequence is located at 
-32 to -81 region, thereby modulate the changes in promoter activity.  As a result, the 
deletion construct pGL3-81/+55Luc shown a full-promoter activity.  Yet, further 
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experiments are needed to demonstrate if these regulatory sequences play any significant 
role in vivo. 
 Mutation analysis identified a HNF1 site at -47/-45 position is crucial for CDH17 
expression. To a lesser extent, CDX2 (-91/-89) regulates the CDH17 promoter activity in 
vitro. Furthermore, both EMSA and ChIP assays demonstrated binding of HNF1 and 
CDX2 to the CDH17 promoter sequences. HNF1α, but not the HNF1β isoform bound to 
the CDH17 promoter and the protein-DNA complex was recognized by HNF1α specific 
antibody. The temporal expression of HNF1α and CDX2 transcript in related to CDH17 
expression was studied in human liver cell lines and mouse liver tissues. It was found that 
an elevated levels of HNF1α and CDX2 expression are closely associated with a higher 
expression of CDH17 in metastatic HCC cell line (MHCC97L >> Hep3B > MIHA) as well 
as in early embryonic mouse liver tissues [E13.5 > E16.5 > new born (NB)]. The role of 
HNF1α, and CDX2 on co-regulating the CDH17 gene expression was further demonstrated 
by iRNA suppression on CDX2 and HNF1α expression in HCC cells. 
 HNF1 and CDX2 are homeodomain transcription factors that regulate a number 
of intestine-specific genes including Lewis type 1 antigen synthase (β3Gal-T5) and 
UDP-glucuronosyltransferases (UGT) [Gregory et al., 2004; Isshiki et al., 2003]. CDX2 
regulates CDH17 expression in colorectal cancer cell lines and gastric adenocarcinoma 
[Barros et al., 2008; Hinoi et al., 2002; Ko et al., 2005]. In this study, 3 putative 
CDX2-binding sites were found in the 1-kb CDH17 promoter region (Fig. 1A) and it is the 
-91/-89 site that contributed to CDH17 promoter activity and binding in HCC. In addition, 
we identified HNF1 homeobox A (HNF1α) that may play an important role in regulating 
Page 17 of 31
John Wiley & Sons, Inc.
Journal of Cellular Biochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 18 
CDH17 transcription in human HCC as well as in mouse fetal liver. Although there are 
three putative HNF1-binding sites in the CDH17 promoter, deletion/mutation studies 
identified -47/-45 position is crucial in regulating CDH17 expression (Fig. 1B and Fig. 2). 
 HNF1α and HNF1β are two related transcriptional factors that bind to DNA as 
homo- or heterodimers. They were identified initially as liver-enriched transcription factors 
that were involved in the expression of several plasma proteins including α1-antitrypsin 
[Mendel and Crabtree, 1991]. However, no detectable HNF1β transcript and protein was 
found in the two HCC cell lines studied (data not shown), and HNF1β failed to bind to 
CDH17 promoter DNA sequence in EMSA or ChIP assays. These findings suggest that 
HNF1α, but not HNF1β is associat d with the regulation of the CDH17 gene in HCC. 
Interestingly, HNF1β has recently been demonstrated to direct the expression of 
kidney-specific cadherin (cadherin-16) [Bai et al., 2002]. 
 In conclusion, the present study provides the first evidence that HNF1α plays a 
critical role, together with CDX2, on the regulation of CDH17 gene expression in HCC as 
well as in early stages of fetal liver development in mice. Clinically, over-expression of 
CDH17 in HCC is associated with poor clinical outcomes; HNF1α and CDX2 in 
accompany with CDH17 may be potential therapeutic targets for disease diagnosis and 
treatment. 
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FIGURE LEGENDS 
 
Figure 1 Cloning and characterization of CDH17 gene promoter.  (A) The 
nucleotide sequences of the 5’-flanking regions of human CDH17 gene and the putative 
transcriptional regulatory elements from -955 were depicted. The G at position +1 indicates 
the transcriptional initiation site based on the GenBank database. The translation start site 
(ATG) is underlined and the amino acid sequences are indicated by bold and capital letters 
above nucleotide sequences. The primer sequences used for making the parental fragment 
and the four deletion constructs were each marked with arrows (forward and reverse 
primers). (B) The promoter activity of CDH17 deletion constructs in Hep3B and 
MHCC97L cells was studied. The pGL-332/+55Luc and pGL-40/+55Luc constructs 
exhibited drastic reduction in luciferase activity (p<0.05 and p<0.01, respectively) when 
compared with the control fragment (pGL-909/+55Luc). The luciferase activity of the 
empty expression vector pGL3-Basic was assigned a value of 1 and the relative activities of 
each construct were normalized with the pRL-TK express on levels. Values are represented 
as mean ± S.D. from at least three independent experiments. 
 
Figure 2  Mutation of Transcriptional factor binding sites on CDH17 promoter 
activity. The relative luciferase activities of mutated HNF1 and CDX2 sites in CDH17 
promoter constructs () were studied in Hep3B and MHCC97L cells. The mutated HNF1 
(filled oval) and/or CDX2 (filled rectangle) binding sites on CDH17 promoters were 
transfected into the HCC cells.  Mutation at the CDX2 (-91 position) and/or HNF1 (-47 
position) binding site(s) significantly reduced (p<0.05 and p<0.01, respectively) the 
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luciferase activity. Combined mutation of these two sites (-91 and -47) also resulted in a 
significant reduction in luciferase activity (p<0.01). Yet, no significant different in 
luciferase activity was found between single (HNF1) and double (HNF1 plus CDX2) sites 
mutation. Values are expressed as mean ± S.D. of at least three independent experiments. 
 
Figure 3  Binding of HNF1 and CDX2 on CDH17 promoter sequence in vitro and 
in vivo. (A) Radiolabeled CDX2 and HNF1 probes (WT and mutant) were incubated with 
Hep3B and MHCC97L nuclear extracts and then resolved on a 5% polyacrylamide gel. The 
presence of CDH17-TF (either CDX2 or HNF1α) complexes suggests binding of TF and 
DNA in vitro. Unbound probes migrated to the bottom of gels. Addition of excessive (10X 
and 50X) specific WT (wt), but not mutant (mut) cold probes reduced the signal 
specifically. While the presence of specific antibodies binds to the TF-DNA complexes 
further retarded the migration of the complex in the gel (supershift). The sequences of the 
probes used were shown at the bottom. (B) ChIP assay was used to detect the presence of 
DNA-TF(CDX2 and HNF1α) complexes in MHCC97L and Hep3B cells in vivo. 
Antibodies against the CDX2, HNF1α, HNF1β, and IgG control, were used to 
immunoprecipitate the TF-DNA complexes. After recovery, the purified DNA was 
amplified by CDH17-specific PCR reaction. Input controls were genomic DNA extracted 
from MHCC97L and Hep3B cells without cross-linking and immunoprecipitation steps. 
 
Figure 4  Expression of CDH17, HNF1α and CDX transcripts in human HCC cells 
and mouse liver. (A) Quantitative PCR was used to quantify the expression of CDH17, 
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HNF1α and CDX2 transcripts. The expression of CDH17, HNF1α and CDX2 transcripts 
were highest in human MHCC97L and lower in Hep3B and MIHA cells; while gradually 
decreases from E13.5, E16.5, new born (NB), 3 weeks old (3 wk) adult mouse liver.  (B) 
Western blot analysis confirmed a high expression level of CDH17, HNF1α and CDX2 
proteins in MHCC97L cells.  A lower expression level was found in Hep3B and MIHA 
cells. The protein expression levels of CDH17 and HNF1α decrease drastically in mouse 
fetal liver from E135 until born. Yet, the expression of CDX2 protein remains constant 
through development. The expression of β-actin protein was used as loading control. 
 
Figure 5  siRNA-mediated knockdown of HNF1α and CDX2 in HCC cells. (A) 
Targeting siRNA oligonucleotides against the HNF1α and CDX2 genes were transfected 
into the CDH17 expressing MHCC97L cells. Quantity of the CDH17, HNF1α and CDX2 
transcripts was measured by real-time qPCR. Vector and scramble siRNA were included as 
controls in each experiments. Data were shown as mean ± S.D. from three independent 
experiments. * denotes statistically significantly different at p<0.05. (B) Western blotting 
demonstrated that CDH17 protein expression was down-regulated after siRNA against 
HNF1α and CDX2. 
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Table 1 Primers used for real-time PCR for detection of transcripts in human liver 
cells and mouse liver tissues 
 
Primer Name Sequence        Product Size 
(bp) 
Human 
CDH17 Forward   5’-GGGGGAGATACTCCAGTCGT-3’    167 
CDH17 Reverse   5’-TCCAGTTGCCAAATAAAGCA-3’ 
CDX2 Forward   5’-GAACCTGTGCGAGTGGATG-3’    158 
CDX2 Reverse   5’-TCCTCCGGATGGTGATGTAG-3’ 
HNF1α Forward   5’-CCATCCTCAAAGAGCTGGAG-3’   173 
HNF1α Reverse   5’-CTGGTTGAGGCCAGTGGTAT-3’ 
 
Mouse  
CDH17 Forward   5’-GGCCAAGAACCGAGTCAAGTC-3’   190 
CDH17 Reverse   5’-CTCCATGAGAATCCAAGGCTG-3’ 
CDX2 Forward   5’-CAAGGACGTGAGCATGTATCC-3’   106 
CDX2 Reverse   5’-GTAACCACCGTAGTCCGGGTA-3’ 
HNF1α Forward   5’-GACCTGACCGAGTTGCCTAAT-3’   103 
HNF1α Reverse   5’-CCGGCTCTTTCAGAATGGGT-3’ 
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